Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Review available methylation, Walsh and functional laboratory testing
Semaglutide is a medication that was initially approved for Type 2 diabetes, but is now allowed to be prescribed for weight loss too
Wegovy side effects Most side effects are mild and temporary
How many people could benefit from the cardioprotective effects of Wegovy
Lose 15% of your body weight with GLP-1s * Lose 15% of your body weight with GLP-1s * *In a 68-week placebo-controlled study of 1,961 obese and overweight non-diabetic adults with weight-related conditions, the treatment group receiving semaglutide experienced a mean body weight loss of 15%, compared to 2% of the placebo group
Absolute contraindications to GLP-1 receptor agonists with the boxed warning include patients with a personal history of MTC, family history of MTC, or known MEN 2 syndrome
